We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$14.8B
AUM Growth
+$2.92B
Cap. Flow
+$3.28B
Cap. Flow %
22.14%
Top 10 Hldgs %
12.56%
Holding
1,029
New
443
Increased
269
Reduced
185
Closed
112

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$217M
2
AAPL icon
Apple
AAPL
+$208M
3
MSFT icon
Microsoft
MSFT
+$199M
4
AMZN icon
Amazon
AMZN
+$136M
5
AJG icon
Arthur J. Gallagher & Co
AJG
+$133M

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$125M
2
GILD icon
Gilead Sciences
GILD
+$107M
3
PR
Permian Resources
PR
+$85.4M
4
RDDT icon
Reddit
RDDT
+$84.1M
5
KEYS icon
Keysight
KEYS
+$79M

Sector Composition

Rank Sector Weight
1 Healthcare 31.96%
2 Technology 25.64%
3 Financials 7.58%
4 Industrials 6.88%
5 Communication Services 6.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNP icon
726
CenterPoint Energy
CNP
$26.8B
$1.24M 0.01%
+39,139
New +$1.21M
ULTA icon
727
Ulta Beauty
ULTA
$23.2B
$1.23M 0.01%
+2,829
New +$1.1M
CBOE icon
728
Cboe Global Markets
CBOE
$29.7B
$1.23M 0.01%
+6,287
New +$1.29M
FE icon
729
FirstEnergy
FE
$27.7B
$1.23M 0.01%
+30,803
New +$1.29M
NTRS icon
730
Northern Trust
NTRS
$33.7B
$1.22M 0.01%
+11,904
New +$1.22M
TNGX icon
731
Tango Therapeutics
TNGX
$4.69B
$1.22M 0.01%
+394,397
New +$1.83M
STE icon
732
Steris
STE
$22.7B
$1.22M 0.01%
+5,928
New +$1.3M
CMS icon
733
CMS Energy
CMS
$22.4B
$1.2M 0.01%
+17,943
New +$1.23M
LYB icon
734
LyondellBasell Industries
LYB
$19.1B
$1.16M 0.01%
+15,602
New +$1.31M
CFG icon
735
Citizens Financial Group
CFG
$31.1B
$1.16M 0.01%
+26,466
New +$1.17M
MKC icon
736
McCormick & Company Non-Voting
MKC
$14.1B
$1.15M 0.01%
+15,145
New +$1.19M
RLAY icon
737
Relay Therapeutics
RLAY
$4.29B
$1.14M 0.01%
276,904
FSLR icon
738
First Solar
FSLR
$25.4B
$1.13M 0.01%
+6,429
New +$1.28M
SANA icon
739
Sana Biotechnology
SANA
$977M
$1.12M 0.01%
690,141
+2,320
+0.3% +$6.92K
CHE icon
740
Chemed
CHE
$7.14B
$1.11M 0.01%
2,092
-35,513
-94% -$20M
NRG icon
741
NRG Energy
NRG
$25.5B
$1.1M 0.01%
+12,165
New +$1.13M
HCA icon
742
HCA Healthcare
HCA
$88.7B
$1.1M 0.01%
3,652
-83,905
-96% -$29.3M
FDS icon
743
Factset
FDS
$9.89B
$1.1M 0.01%
2,282
+1,768
+344% +$840K
INVH icon
744
Invitation Homes
INVH
$18.1B
$1.09M 0.01%
+34,069
New +$1.14M
BBOT
745
BridgeBio Oncology
BBOT
$718M
$1.08M 0.01%
103,247
LVS icon
746
Las Vegas Sands
LVS
$29.7B
$1.07M 0.01%
+20,900
New +$1.08M
SNA icon
747
Snap-on
SNA
$21.7B
$1.07M 0.01%
+3,153
New +$1.06M
EDIT icon
748
Editas Medicine
EDIT
$422M
$1.06M 0.01%
838,419
-62,002
-7% -$158K
WRB icon
749
W.R. Berkley
WRB
$26.8B
$1.06M 0.01%
+18,079
New +$1.08M
SCPH
750
DELISTED
scPharmaceuticals
SCPH
$1.05M 0.01%
297,800
-203,808
-41% -$781K

Similar funds

Woodline Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Woodline Partners held 1,029 positions worth $14.8B, up 25% from $11.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Woodline Partners deployed $3.28B of net new capital in Q4 2024, opening 443 new positions and adding to 269 existing holdings. Its largest new stake was TE Connectivity: 890,754 shares worth $127M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 43% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $107M trimmed.

  • Woodline Partners's largest Q4 2024 buy was TE Connectivity: 890,754 shares worth $127M.
  • Woodline Partners added most to NVIDIA in Q4 2024, an estimated $217M increase.
  • Woodline Partners's biggest Q4 2024 reduction was Gilead Sciences, cutting an estimated $107M.
  • Woodline Partners fully exited ASML in Q4 2024, selling an estimated $125M.
  • Woodline Partners's ten largest holdings make up 13% of its $14.8B portfolio in Q4 2024.
  • Woodline Partners opened 443 new positions and closed 112 in Q4 2024.
  • Woodline Partners's portfolio value rose 25% quarter-over-quarter to $14.8B.

Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.